Delivery Order SPE2DR25D1053-SPE2DR26FV190
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,879.12 by the Defense Logistics Agency on October 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,469.78 by the Defense Logistics Agency on December 11, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 5, 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on September 3, 2025, with an ultimate completion date of September 24, 2025. The delivery order is for Tezspire 210 mg/1.91 mL pen injectors and will be performed at the company's Conshohocken facility. This award was competitively procured with no set-aside designation and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 on July 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by August 11, 2025, with performance taking place at the company's Conshohocken facility. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 18, 2025. The award supports the company's role as a critical pharmaceutical distributor within the federal medical supply chain, with performance originating from the vendor's...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 12, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with a ceiling value of $4,939.58 and a firm fixed price structure. The order is scheduled for completion by January 6, 2026, with performance to be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $46,871.80 by the Defense Logistics Agency on September 19, 2025. The contract calls for the supply of Tezspire 210 mg/1.91 mL pen injectors and is expected to be completed by October 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This firm fixed price delivery order, valued at $4,939.58, is scheduled for completion by December 17, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of May 15, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award is a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 21, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV190Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,409.34 by the Defense Logistics Agency on January 5, 2026, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 27, 2026, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order supports the Defense Logistics Agency's pharmaceutical supply mission for military healthcare systems and other federal medical procurement needs. Tezspire is a biologic therapeutic used for moderate-to-severe asthma management, reflecting AmerisourceBergen's broad portfolio of specialty medications and brand-name pharmaceuticals supplied to the Department of Defense and affiliated healthcare organizations. The contract exemplifies the company's role as a critical vendor within the Defense Health Agency's medical supply chain, delivering specialized medical commodities to support military readiness and healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 1/4/26 |